Screening for ADHD
Screening recommendations vary depending on the clinical setting. The American Academy of Pediatrics recommends that the primary care clinician should initiate an evaluation for ADHD for any child from 4 to 18 years of age who presents with academic or behavioral problems and symptoms of inattention, hyperactivity, or impulsivity.[90]Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019 Oct;144(4):e20192528.
https://pediatrics.aappublications.org/content/144/4/e20192528
http://www.ncbi.nlm.nih.gov/pubmed/31570648?tool=bestpractice.com
Clinicians should be aware that:
The presenting symptom in preschool children is often hyperactivity, while inattention is more prevalent among adolescents with ADHD.
ADHD is likely under-recognized and underdiagnosed in girls.[18]Sayal K, Prasad V, Daley D, et al. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry. 2018 Feb;5(2):175-86.
http://www.ncbi.nlm.nih.gov/pubmed/29033005?tool=bestpractice.com
Screening for comorbidities
The American Academy of Pediatrics recommends that clinicians should screen for comorbid conditions when evaluating a child or adolescent for ADHD (e.g., anxiety, depression, oppositional defiant disorder, conduct disorders, substance use), developmental conditions (e.g., learning and language disorders, autism spectrum disorders), and physical conditions (e.g., tics, sleep apnea).[90]Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019 Oct;144(4):e20192528.
https://pediatrics.aappublications.org/content/144/4/e20192528
http://www.ncbi.nlm.nih.gov/pubmed/31570648?tool=bestpractice.com
For substance misuse screening, the 2-question National Institute on Alcohol Abuse and Alcoholism Youth Alcohol Screening Tool is suitable for children as young as 9 years.[110]Barbaresi WJ, Campbell L, Diekroger EA, et al. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. J Dev Behav Pediatr. 2020 Feb/Mar;41 Suppl 2S:S35-S57.
https://www.doi.org/10.1097/DBP.0000000000000770
http://www.ncbi.nlm.nih.gov/pubmed/31996577?tool=bestpractice.com
Beginning at age 12 years, the Screening to Brief Intervention approach (SBIRT) is preferred.[111]Levy SJ, Williams JF, Committee On Substance Use And Prevention. Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016 Jul;138(1):e20161211.
https://publications.aap.org/pediatrics/article/138/1/e20161211/52568/Substance-Use-Screening-Brief-Intervention-and?autologincheck=redirected
http://www.ncbi.nlm.nih.gov/pubmed/27325634?tool=bestpractice.com
Identification of suspected or confirmed substance use disorder requires immediate brief intervention and referral to an addiction or mental health specialist.[110]Barbaresi WJ, Campbell L, Diekroger EA, et al. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. J Dev Behav Pediatr. 2020 Feb/Mar;41 Suppl 2S:S35-S57.
https://www.doi.org/10.1097/DBP.0000000000000770
http://www.ncbi.nlm.nih.gov/pubmed/31996577?tool=bestpractice.com